Works about GLUCAGON-like peptide-1 agonists
Results: 2529
Effects of semaglutide in patients with chronic ankle instability: evidence from a prospective cohort.
- Published in:
- Journal of Orthopaedic Surgery & Research, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13018-025-05664-9
- By:
- Publication type:
- Article
GLP-1 receptor agonists—another promising therapy for Alport syndrome?
- Published in:
- Journal of Rare Diseases, 2025, v. 4, n. 1, p. 1, doi. 10.1007/s44162-024-00065-8
- By:
- Publication type:
- Article
Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-01878-9
- By:
- Publication type:
- Article
Impact of Fasting on Physical Activity Motivation and Weight Reduction in Patients Administered Glucagon-Like Peptide-1 Agonists: A Qualitative Study.
- Published in:
- Patient Preference & Adherence, 2025, v. 19, p. 19, doi. 10.2147/PPA.S496613
- By:
- Publication type:
- Article
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 238, doi. 10.3390/pharmaceutics17020238
- By:
- Publication type:
- Article
Diabetic Ketoacidosis and the Use of New Hypoglycemic Groups: Real-World Evidence Utilizing the Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 214, doi. 10.3390/ph18020214
- By:
- Publication type:
- Article
Exploring the Putative Involvement of MALAT1 in Mediating the Beneficial Effect of Exendin-4 on Oleic Acid-Induced Lipid Accumulation in HepG2 Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 370, doi. 10.3390/biomedicines13020370
- By:
- Publication type:
- Article
Advances in GLP-1 receptor agonists for pain treatment and their future potential.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-01979-4
- By:
- Publication type:
- Article
Diabetes Mellitus in Kidney Transplant Recipients: New Horizons in Treatment.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1048, doi. 10.3390/jcm14041048
- By:
- Publication type:
- Article
Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.
- Published in:
- Clinical Infectious Diseases, 2025, v. 80, n. 2, p. 389, doi. 10.1093/cid/ciae384
- By:
- Publication type:
- Article
A Hypothesis That Glucagon-like Peptide-1 Receptor Agonists Exert Immediate and Multifaceted Effects by Activating Adenosine Monophosphate-Activate Protein Kinase (AMPK).
- Published in:
- Life (2075-1729), 2025, v. 15, n. 2, p. 253, doi. 10.3390/life15020253
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 (SGLT2) inhibitors and risk of chronic kidney disease–mineral and bone disorders in patients with type 2 diabetes mellitus and stage 1–3 chronic kidney disease.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2025, v. 197, n. 7, p. E178, doi. 10.1503/cmaj.240922
- By:
- Publication type:
- Article
Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling.
- Published in:
- Infectious Disease Reports, 2025, v. 17, n. 1, p. 5, doi. 10.3390/idr17010005
- By:
- Publication type:
- Article
"An injection a day may keep CLI away?".
- Published in:
- Diabetic Foot Journal, 2024, v. 27, n. 1, p. 58
- By:
- Publication type:
- Article
Diabetes Care.
- Published in:
- Diabetic Foot Journal, 2018, v. 21, n. 3, p. 206
- Publication type:
- Article
Examining the results of cardiovascular outcome trials.
- Published in:
- Practice Nursing, 2019, v. 30, n. 2, p. 87, doi. 10.12968/pnur.2019.30.2.87
- By:
- Publication type:
- Article
New pharmacological approaches to diabetes management.
- Published in:
- Practice Nursing, 2015, v. 26, n. 3, p. 140, doi. 10.12968/pnur.2015.26.3.140
- By:
- Publication type:
- Article
Evolving Type 2 diabetes management focuses on clinical outcomes.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 4, p. 165, doi. 10.1007/s40267-022-00903-z
- By:
- Publication type:
- Article
Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists.
- Published in:
- Journal of Women's Health (15409996), 2021, v. 30, n. 7, p. 1016, doi. 10.1089/jwh.2020.8683
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonists for Abdominal Aortic Aneurysm?
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 13, doi. 10.1007/s10557-024-07647-0
- By:
- Publication type:
- Article
International Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards.
- Published in:
- Cardiovascular Drugs & Therapy, 2025, v. 39, n. 1, p. 9, doi. 10.1007/s10557-024-07630-9
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Inhibits the Progression of Abdominal Aortic Aneurysm in Mice: The Earlier, the Better.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 5, p. 873, doi. 10.1007/s10557-023-07456-x
- By:
- Publication type:
- Article
Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 739, doi. 10.1007/s10557-023-07432-5
- By:
- Publication type:
- Article
Effects of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) on Cardiac Structure and Function: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 2, p. 371, doi. 10.1007/s10557-022-07360-w
- By:
- Publication type:
- Article
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 3, p. 561, doi. 10.1007/s10557-021-07291-y
- By:
- Publication type:
- Article
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2021, v. 35, n. 6, p. 1161, doi. 10.1007/s10557-021-07160-8
- By:
- Publication type:
- Article
Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 4, p. 365, doi. 10.1007/s10157-020-02007-2
- By:
- Publication type:
- Article
Sodium‐glucose co‐transporter‐2 inhibitors and the risk of venous thromboembolism: A nationwide population‐based study and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3739
- By:
- Publication type:
- Article
Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 2, p. 1, doi. 10.1002/dmrr.3727
- By:
- Publication type:
- Article
Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 8, p. 1, doi. 10.1002/dmrr.3699
- By:
- Publication type:
- Article
Effects of treatment with Glucagon‐like peptide‐1 receptor agonist on prediabetes with overweight/obesity: A systematic review and meta‐analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3680
- By:
- Publication type:
- Article
Pleiotropic effects of GLP‐1 receptor agonists on peripheral artery disease: Is there any hope?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3627
- By:
- Publication type:
- Article
GLP‐1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2022, v. 38, n. 8, p. 1, doi. 10.1002/dmrr.3574
- By:
- Publication type:
- Article
The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 8, p. 1, doi. 10.1002/dmrr.3503
- By:
- Publication type:
- Article
Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 7, p. 1, doi. 10.1002/dmrr.3434
- By:
- Publication type:
- Article
Is time ready for combination therapy at diagnosis of type 2 diabetes?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The use of GLP-1 receptor agonists in hospitalised patients: An untapped potential.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exenatide modulates visual cortex responses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Liraglutide on Osteoporosis in a Rat Model of Type 2 Diabetes Mellitus: A Histological, Immunohistochemical, and Biochemical Study.
- Published in:
- Microscopy & Microanalysis, 2023, v. 29, n. 6, p. 2053, doi. 10.1093/micmic/ozad102
- By:
- Publication type:
- Article
Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2469, doi. 10.1007/s10067-023-06647-z
- By:
- Publication type:
- Article
Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation.
- Published in:
- Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-021-01302-x
- By:
- Publication type:
- Article
Pharmacological management of pediatric metabolic dysfunction-associated steatotic liver disease.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2025, v. 80, n. 1, p. 14, doi. 10.1002/jpn3.12402
- By:
- Publication type:
- Article
Utilization and perspectives of weight loss medications in pediatric metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Journal of Pediatric Gastroenterology & Nutrition, 2024, v. 79, n. 3, p. 661, doi. 10.1002/jpn3.12236
- By:
- Publication type:
- Article
'No Observed Increase' in Pancreatic Cancer Among Patients with Type 2 Diabetes on GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 37
- By:
- Publication type:
- Article
A Clear Liquid Diet Prior to GI Endoscopy May be 'More Important' Than Holding GLP-1RAs.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 34
- By:
- Publication type:
- Article
GLP-1RAs May Offer 'Hepatoprotective' Benefit for Diabetes, Alcohol-Related Liver Disease.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 12, p. 32
- By:
- Publication type:
- Article
GLP-1RA Use Linked to Lower Risk for Cirrhosis, Mortality in MASLD With Diabetes.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 11, p. 38
- By:
- Publication type:
- Article